ABSTRACT
The burst of superoxide produced when neutrophils phagocytose bacteria is the defining biochemical feature of these abundant immune cells. But 50 years since this discovery, the vital role superoxide plays in host defense has yet to be defined. Superoxide is neither bactericidal nor is it just a source of hydrogen peroxide. This simple free radical does, however, have remarkable chemical dexterity. Depending on its environment and reaction partners, superoxide can act as an oxidant, a reductant, a nucleophile, or an enzyme substrate. We outline the evidence that inside phagosomes where neutrophils trap, kill, and digest bacteria, superoxide will react preferentially with the enzyme myeloperoxidase, not the bacterium. By acting as a cofactor, superoxide will sustain hypochlorous acid production by myeloperoxidase. As a substrate, superoxide may give rise to other forms of reactive oxygen. We contend that these interactions hold the key to understanding the precise role superoxide plays in neutrophil biology. State-of-the-art techniques in mass spectrometry, oxidant-specific fluorescent probes, and microscopy focused on individual phagosomes are needed to identify bactericidal mechanisms driven by superoxide. This work will undoubtably lead to fascinating discoveries in host defense and give a richer understanding of superoxide's varied biology.
Subject(s)
Neutrophils , Superoxides , Humans , Neutrophils/microbiology , Superoxides/pharmacology , Peroxidase/pharmacology , Phagocytosis , Oxidants/pharmacology , Hypochlorous Acid/analysis , Hypochlorous Acid/pharmacology , Anti-Bacterial Agents , BiologyABSTRACT
The cuttage rooting method for Acer species is difficult to achieve a good efficacy as trees maintain good characteristics at the rejuvenation stage, thus improving the rooting of Acer species. The addition of exogenous hormones and rejuvenation can improve the rooting effect of cuttings; however, the specific regulatory mechanism is still unclear. Here, Acer mono Maxim rejuvenation and non-rejuvenation cuttings were used as test subjects, to investigate the effects of exogenous hormones on the activities of endogenous hormones and antioxidant enzymes in the rooting process of young cuttings. The results showed that exogenous growth-regulating substances significantly improved the rooting rate of A. mono. Exogenous hormones naphthylacetic acid (NAA) + indolebutyric acid (IBA) increased the initial levels of the endogenous hormones, indoleacetic acid (IAA) and abscisic acid (ABA), and the enzyme activities of peroxidase (POD) and polyphenol oxidase (PPO). Rejuvenation treatment prolonged the time of increase in ABA content and indoleacetic acid oxidase (IAAO) activity at the root primordium induction stage, while increasing trans-zeatin riboside (ZR) content and decreasing POD enzyme activity in cuttings. These results demonstrate that A. mono cuttings can achieve the purpose of improving the rooting rate by adding the exogenous hormone (NAA + IBA), which is closely related to the changes of endogenous hormone content and enzyme activity, and these changes of A. mono rejuvenation cuttings are different from non-rejuvenation cuttings.
Subject(s)
Acer , Plant Growth Regulators , Humans , Plant Growth Regulators/pharmacology , Plant Roots , Indoleacetic Acids/pharmacology , Abscisic Acid/pharmacology , Oxidoreductases , Peroxidases , Peroxidase/pharmacology , Hormones/pharmacologyABSTRACT
This study aims to examine the effects of Arsenite (As+3) and Arsenate (As+5) on the aquatic macrophyte Amazon Sword Plant (Echinodorus amazonicus Rataj). To this aim, different concentrations of As+3 and As+5 (0, 6, 18 and 54 µM) were analyzed. At the end of the trail, photosynthetic pigment contents, total protein amounts, the enzymatic antioxidants superoxide dismutase (SOD), peroxidase (POX) and catalase (CAT) activities and the amount of malondialdehyde (MDA) in the leaf samples of E. amazonicus were investigated. The antioxidant enzyme activities increased at low concentrations (32.13% for SOD, 185% for CAT and 201.5% for POX in the groups of 6 µM As+5), but decreased at high concentrations (64.98% for SOD, 21.64% for CAT and 21.29% for POX in the groups of 54 µM As+3). MDA increased in all the treatment groups. The highest MDA contents were observed as 96% for 54 µM As+3 and 71.50% for 54 µM As+5. Photosynthetic pigment contents and the amount of protein were decreased with higher concentrations. The most significant decreases in protein content were 65% for 54 µM As+3 and 34.9% for 54 µM As+5. As a result, the toxicity of As+3 was higher and the toxic effect increased at higher concentrations.
Subject(s)
Alismataceae , Arsenic , Arsenicals , Antioxidants/metabolism , Antioxidants/pharmacology , Catalase/metabolism , Catalase/pharmacology , Arsenic/toxicity , Superoxide Dismutase/metabolism , Superoxide Dismutase/pharmacology , Arsenicals/pharmacology , Peroxidase/metabolism , Peroxidase/pharmacology , Alismataceae/metabolism , Oxidative StressABSTRACT
OBJECTIVES: To investigate the effects of pretreatment with 5-aminolevulinic acid hydrochloride combined with sodium ferrous citrate on bladder dysfunction in cyclophosphamide-induced hemorrhagic cystitis in rats. METHODS: Male Wistar rats (340-460 g) were pretreated with vehicle or with 5-aminolevulinic acid hydrochloride combined with sodium ferrous citrate (100/157 or 300/471 mg/kg/day, po) once daily for 7 days before cystometry. Saline or cyclophosphamide (150 mg/kg, ip) was administered 2 days before cystometry. Cystometry was performed under urethane anesthesia (0.8 g/kg, ip) via a catheter inserted into the bladder. After cystometry, bladder tissues were collected to perform hematoxylin and eosin staining for pathological evaluation (neutrophil infiltration, edema, and bleeding scores), and for enzyme-linked immunosorbent assay and real-time polymerase chain reaction for investigating tissue levels of myeloperoxidase, and mRNA levels of haem oxygenase-1 as a cytoprotective molecule. RESULTS: Compared to controls, cyclophosphamide induced a shorter intercontraction interval, lower bladder compliance, increased number of non-voiding contractions, and increased pathological scores and myeloperoxidase expression in the bladder. Pretreatment with 5-aminolevulinic acid hydrochloride combined with sodium ferrous citrate (300/471 mg/kg/day) significantly improved cyclophosphamide-induced intercontraction interval shortening and increases in number of non-voiding contractions and neutrophil infiltration/bleeding scores and enhanced haem oxygenase-1 expression in the bladder. In addition, cyclophosphamide-induced decreases in bladder compliance and increases in myeloperoxidase were not detected with 5-aminolevulinic acid hydrochloride combined with sodium ferrous citrate pretreatment. CONCLUSIONS: Pretreatment with 5-aminolevulinic acid expects protective effects on bladder dysfunction in cyclophosphamide-induced hemorrhagic cystitis by improving inflammatory changes in bladder tissues perhaps via up-regulation of haem oxygenase-1.
Subject(s)
Aminolevulinic Acid , Cystitis , Aminolevulinic Acid/adverse effects , Animals , Cyclophosphamide/adverse effects , Cystitis/chemically induced , Cystitis/prevention & control , Male , Peroxidase/metabolism , Peroxidase/pharmacology , Rats , Rats, Wistar , Urinary Bladder/pathologyABSTRACT
The present study investigated the individual and collective effect of organochlorinated fungicide hexachlorobenzene (HCB) and manganese (Mn), a metal, on the hepatorenal function in adult rats. Rats were divided into four groups of rats comprising of control, HCB alone (15 mg/kg), Mn alone (10 mg/kg) and co-exposure group that were orally treated for 25 consecutive days. After sacrifice, hepatorenal damage and antioxidant status markers, myeloperoxidase (MPO) activity, levels of nitric oxide, total antioxidant capacity (TAC), total oxidative stress (TOS) and lipid peroxidation (LPO) were analyzed spectrophotometrically. Levels of tumor necrosis factor alpha (TNF-α), interleukin-1 ß (IL-1ß) and caspase-3 activity were assessed using ELISA. Results revealed that the HCB administration significantly (p < 0.05) increased the biomarkers of hepatorenal toxicity, decreased the antioxidant status and TAC, raised the levels of TOS and LPO as well as increased the levels of TNF-α, IL-1ß and caspase-3 activity. Rats co-exposed to HCB and Mn showed decreased biomarkers of hepatorenal damage, increased antioxidant status and TAC with simultaneous reduction in the levels of TOS and LPO significantly (p < 0.05). Furthermore, the increased levels of TNF-α, IL-1ß and caspase-3 activity were significantly (p < 0.05) reduced in the liver and kidney of rats' co-expose to HCB and Mn. Histological examination showed that damages induced by HCB were assuaged in rats co-treated with HCB and Mn. In conclusion, the results demonstrated that co-treatment of HCB and Mn in rats' alleviated HCB-induced oxidative stress, inflammation and caspase-3 activation in the liver and kidney of the rats.
Subject(s)
Fungicides, Industrial , Hexachlorobenzene , Animals , Rats , Antioxidants/pharmacology , Antioxidants/metabolism , Biomarkers/metabolism , Caspase 3/metabolism , Fungicides, Industrial/toxicity , Hexachlorobenzene/toxicity , Hexachlorobenzene/metabolism , Inflammation/chemically induced , Inflammation/pathology , Interleukin-1beta/metabolism , Liver , Manganese/pharmacology , Nitric Oxide/metabolism , Oxidative Stress , Peroxidase/metabolism , Peroxidase/pharmacology , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Fluoroquinolones (FQs) are synthetic and broad-spectrum antimicrobial drugs derived from nalidixic acid. FQs are used against SARS-CoV-2 in our country, and for the treatment of some urinary tract diseases, gastrointestinal diseases, respiratory tract diseases, sexually transmitted diseases, and dermatological diseases. The present study investigated the effect of 1-,7-,14-day treatments of three different FQ derivatives; ciprofloxacin (CIP) 80 mg/kg/day, levofloxacin (LVX) 40 mg/kg/day, and moxifloxacin (MXF) 40 mg/kg/day, on biochemical parameters, lipid peroxidation, antioxidant enzymes, and immunotoxicity. 72 Wistar albino male rats were distributed to four groups including 18 rats in each group and were sacrificed on three different time points. The 14-day treatment of MXF significantly reduced the levels of aspartate aminotransferase (AST), glucose, reduced glutathione (GSH), malondialdehyde (MDA), catalase (CAT), myeloperoxidase (MPO), adenosine deaminase (ADA), and glutathione peroxidase (GPx). Furthermore, 14-day treatment of LVX increased liver [GSH, MPO, ADA, superoxide dismutase (SOD)], and GSH (erythrocyte) levels; whereas it significantly reduced the levels of AST, TG (triglycerides) and associated parameters levels in all the tissues (MDA), erythrocytes, and liver (MPO, CAT, SOD, GPx). After 14-day treatment of CIP; the erythrocyte levels of GSH, MPO, GPx, and CAT significantly decreased; whereas the levels of glucose, creatinine, MPO (liver), and GST (kidney and erythrocyte) significantly increased. It has been concluded that FQ derivatives used in this experiment did not display any correlation in terms of the efficacies in the different time points and tissues. Thus, it is recommended to use such FQ derivatives considering the duration of use and target tissue.
Subject(s)
Antioxidants , COVID-19 , Animals , Rats , Antioxidants/pharmacology , Antioxidants/metabolism , Catalase/metabolism , Glutathione Peroxidase/metabolism , Peroxidase/pharmacology , Adenosine Deaminase/pharmacology , Fluoroquinolones/toxicity , Creatinine , Levofloxacin/pharmacology , Moxifloxacin/pharmacology , Nalidixic Acid/pharmacology , Rats, Wistar , SARS-CoV-2 , Lipid Peroxidation , Glutathione/metabolism , Malondialdehyde , Superoxide Dismutase/metabolism , Triglycerides , Aspartate Aminotransferases , Glucose , Ciprofloxacin/pharmacology , Oxidative StressABSTRACT
Fluorouracil (5-FU) is a widely used chemotherapeutic agent in various malignant tumors. However, intestinal toxicity is considered the irritant unavoidable adverse effect during the course therapy. The aim of the current study was to screen the effect of a new selective histamine receptor 1 blocker and platelet-activating factor (PAF) blocker on 5-FU induced intestinal toxicity. Five groups (6 rats each) of adult male rats (Wistar) were arranged as follows: (1) control group that was treated with carboxymethylcellulose, (2) a group that received rupatadine (higher dose) only, (3) a group that received 5-FU and (4) and (5) groups that received 5-FU plus lower or higher dose rupatadine, respectively. At end of the experiment, we determined intestinal malondialdehyde (MDA), glutathione reduced (GSH), nitric oxide (NO), tumor necrosis factor (TNF-α), interleukin 1ß, 6, 10 (IL-1ß, IL-6, IL-10), PAF, histamine, myeloperoxidase, cysteine-aspartic acid protease-3 (caspase-3), and nuclear factor kappa B (NF-κB) as well as the histological analysis. 5-FU injection caused marked elevation of MDA, NO, TNF-α, IL-1ß, IL-6, PAF, histamine, myeloperoxidase, caspase-3, and NF-κB expressions. The intoxicated animals showed deficient GSH and IL-10 along with significant loss of villi, disorganized crypts, and inflammatory cell infiltration. Rupatadine pretreatment reduced the previously mentioned parameters, preserved a nearly normal intestinal mucosa picture with replenished GSH and elevated IL-10. In conclusion, rupatadine is a dual histamine receptor 1, and a PAF blocker could reduce 5-FU-induced oxidative damage, inflammation, apoptosis, and ulceration of the intestinal epithelium. Rupatadine may be a valuable modality to decrease 5-FU induced intestinal mucositis.
Subject(s)
Aspartic Acid Proteases , Peroxidase , Animals , Male , Rats , Apoptosis , Aspartic Acid Proteases/metabolism , Aspartic Acid Proteases/pharmacology , Carboxymethylcellulose Sodium/metabolism , Carboxymethylcellulose Sodium/pharmacology , Caspase 3/metabolism , Cysteine , Fluorouracil/adverse effects , Fluorouracil/toxicity , Glutathione/metabolism , Histamine/metabolism , Histamine/pharmacology , Inflammation/chemically induced , Inflammation/prevention & control , Interleukin-10/metabolism , Interleukin-1beta/metabolism , Interleukin-6 , Intestinal Mucosa/metabolism , Irritants , Malondialdehyde/metabolism , NF-kappa B , Nitric Oxide/metabolism , Permeability , Peroxidase/metabolism , Peroxidase/pharmacology , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolismABSTRACT
UV radiation can cause damages, such as erythema, skin photoaging, and carcinogenesis. The adoption of protective measures against sun exposure is essential to prevent these damages, and the interest in using natural substances as an alternative for photoprotection is growing. Thus, hesperetin with antioxidant, anti-inflammatory, and anticancer properties is a promising substance to be used with photochemopreventive action and to protect the skin from damage induced by UV radiation. Therefore, the present study aimed to develop a topical formulation based on AAMVPC gel containing hesperetin and evaluate its photoprotective effect on the skin of rats exposed to UVA-UVB radiation. The animals were submitted to the irradiation protocol UVA-UVB, and at the end, erythema, lipid peroxidation, and activity of the antioxidant enzyme catalase and superoxide dismutase were evaluated. Additionally, it evaluated the activity of myeloperoxidase and histological changes. The formulation presented a rheological and spreadability profile suitable for cutaneous application. In vivo results demonstrated that the topical formulation of AAMVPC gel containing hesperetin at a concentration of 10% protected the skin from damage induced by UVA-UVB radiation, with the absence of erythema, lipid lipoperoxidation, and inflammation (low myeloperoxidase activity), and increased catalase and superoxide dismutase activities. The morphology and architecture of the dermo-epidermal tissue of these animals were like those observed under normal conditions (non-irradiated animals). Thus, the results showed that hesperetin was able to protect the animals' skin against UV radiation-induced skin damage and the protection mechanisms may be related to the antioxidant and anti-inflammatory properties of this natural product.
Subject(s)
Peroxidase , Ultraviolet Rays , Animals , Anti-Inflammatory Agents/metabolism , Antioxidants/metabolism , Antioxidants/pharmacology , Catalase , Hesperidin , Hydrogels/metabolism , Oxidative Stress , Peroxidase/metabolism , Peroxidase/pharmacology , Rats , Skin/metabolism , Superoxide Dismutase/metabolism , Superoxide Dismutase/pharmacology , Ultraviolet Rays/adverse effectsABSTRACT
A new type of nitrogen-iodine co-doped carbon dot (N/I-CD) was synthesized by a one-step hydrothermal method with a fluorescence quantum yield of 37%. The prepared N/I-CDs exhibit peroxidase-like activity, can catalyze bio-safety levels of H2O2 to generate hydroxyl radicals (â¢OH) under visible light and enhance the level of reactive oxygen species (ROS) in bacteria cells. All in vitro experiments showed that the designed system has strong photocatalytic antibacterial activity against both E. coli and S. aureus bacteria. The light-induced antibacterial function of N/I-CDs was evaluated under the conditions of changing other experimental parameters. When the visible light irradiation time was extended to 60 min, the antibacterial efficiency of N/I-CDs (0.21 mg·mL-1) against S. aureus and E. coli reached 100% in the presence of exogenous H2O2 (0.07 mM). More importantly, wound disinfection in vivo demonstrates the high antibacterial efficiency, low toxicity and application potential of good biocompatibility due to the nanozyme activity of N/I-CDs.
Subject(s)
Anti-Bacterial Agents/pharmacology , Carbon/pharmacology , Iodine/pharmacology , Wound Healing/drug effects , Animals , Anti-Bacterial Agents/chemistry , Carbon/chemistry , Catalysis , Escherichia coli/drug effects , Escherichia coli Infections/drug therapy , HT29 Cells , Humans , Iodine/chemistry , Nanoparticles/chemistry , Peroxidase/chemistry , Peroxidase/pharmacology , Rats, Sprague-Dawley , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effectsABSTRACT
Metal-oxide nanoparticles (MO-NPs), such as the highly bioreactive copper-based nanoparticles (CuO-NPs), are widely used in manufacturing of hundreds of commercial products. Epidemiological studies correlated levels of nanoparticles in ambient air with a significant increase in lung disease. CuO-NPs, specifically, were among the most potent in a set of metal-oxides and carbons studied in parallel regarding DNA damage and cytotoxicity. Despite advances in nanotoxicology research and the characterization of their toxicity, the exact mechanism(s) of toxicity are yet to be defined. We identified chlorination toxicity as a damaging consequence of inflammation and myeloperoxidase (MPO) activation, resulting in macromolecular damage and cell damage/death. We hypothesized that the inhalation of CuO-NPs elicits an inflammatory response resulting in chlorination damage in cells and lung tissues. We further tested the protective action of LGM2605, a synthetic small molecule with known scavenging properties for reactive oxygen species (ROS), but most importantly, for active chlorine species (ACS) and an inhibitor of MPO. CuO-NPs (15 µg/bolus) were instilled intranasally in mice and the kinetics of the inflammatory response in lungs was evaluated 1, 3, and 7 days later. Evaluation of the protective action of LGM2605 was performed at 24 h post-challenge, which was selected as the peak acute inflammatory response to CuO-NP. LGM2605 was given daily via gavage to mice starting 2 days prior to the time of the insult (100 mg/kg). CuO-NPs induced a significant inflammatory influx, inflammasome-relevant cytokine release, and chlorination damage in mouse lungs, which was mitigated by the action of LGM2605. Preventive action of LGM2605 ameliorated the adverse effects of CuO-NP in lung.
Subject(s)
Butylene Glycols/pharmacology , Glucosides/pharmacology , Inflammation/drug therapy , Animals , Bronchoalveolar Lavage Fluid/cytology , Butylene Glycols/metabolism , Chlorine/metabolism , Copper/metabolism , Copper/toxicity , DNA Damage/drug effects , Female , Glucosides/metabolism , Inflammasomes/drug effects , Lung/drug effects , Metal Nanoparticles/adverse effects , Mice , Mice, Inbred C57BL , Oxidative Stress , Oxides/pharmacology , Peroxidase/pharmacology , Reactive Oxygen Species/pharmacologyABSTRACT
The effect of exposure to high Mn concentration was studied in a metallophyte species, Erica andevalensis, using hydroponic cultures with a range of Mn concentrations (0.06, 100, 300, 500, and 700 mg L-1). At harvest, biomass production, element uptake, and biochemical indicators of metal stress (leaf pigments, organic acids, amino acids, phenols, and activities of catalase, peroxidase, superoxide dismutase) were determined in leaves and roots. Increasing Mn concentrations led to a decrease in biomass accumulation, and tip leaves chlorosis was the only toxicity symptom detected. In a similar way, photosynthetic pigments (chlorophylls a and b, and carotenoids) were affected by high Mn levels. Among organic acids, malate and oxalate contents in roots showed a significant increase at the highest Mn concentration, while in leaves, Mn led to an increasing trend in citrate and malate contents. An increase of Mn also induced an increase in superoxide dismutase activity in roots and catalase activity in leaves. As well, significant changes in free amino acids were induced by Mn concentrations higher than 300 mg L-1, especially in roots. No significant changes in phenolic compounds were observed in the leaves, but root phenolics were significantly increased by increasing Mn concentrations in treatments. When Fe supply was increased 10 and 20 times (7-14 mg Fe L-1 as Fe-EDDHA) in the nutrient solutions at the highest Mn concentration (700 mg Mn L-1), it led to significant increases in photosynthetic pigments and biomass accumulation. Manganese was mostly accumulated in the roots, and the species was essentially a Mn excluder. However, considering the high leaf Mn concentration recorded without toxicity symptoms, E. andevalensis might be rated as a Mn-tolerant species.
Subject(s)
Adaptation, Physiological , Ericaceae/physiology , Manganese/toxicity , Antioxidants/metabolism , Biomass , Catalase/metabolism , Chlorophyll/metabolism , Ericaceae/drug effects , Ericaceae/enzymology , Ericaceae/metabolism , Peroxidase/analysis , Peroxidase/metabolism , Peroxidase/pharmacology , Photosynthesis/drug effects , Plant Leaves/metabolism , Plant Roots/metabolism , Superoxide Dismutase/metabolismABSTRACT
Innate immune recognition is classically mediated by the interaction of host pattern-recognition receptors and pathogen-associated molecular patterns; this triggers a series of downstream signaling events that facilitate killing and elimination of invading pathogens. In this report, we provide the first evidence that peroxidasin (PXDN; also known as vascular peroxidase-1) directly binds to gram-negative bacteria and mediates bactericidal activity, thus, contributing to lung host defense. PXDN contains five leucine-rich repeats and four immunoglobulin domains, which allows for its interaction with lipopolysaccharide, a membrane component of gram-negative bacteria. Bactericidal activity of PXDN is mediated via its capacity to generate hypohalous acids. Deficiency of PXDN results in a failure to eradicate Pseudomonas aeruginosa and increased mortality in a murine model of Pseudomonas lung infection. These observations indicate that PXDN mediates previously unrecognized host defense functions against gram-negative bacterial pathogens.
Subject(s)
Extracellular Matrix Proteins/metabolism , Extracellular Matrix Proteins/pharmacology , Gram-Negative Bacteria/drug effects , Peroxidase/metabolism , Peroxidase/pharmacology , Animals , Anti-Bacterial Agents/immunology , Anti-Bacterial Agents/metabolism , Escherichia coli/drug effects , Escherichia coli/immunology , Female , Gram-Negative Bacteria/immunology , Immunity, Innate/immunology , Lung/immunology , Lung/microbiology , Male , Mice , Mice, Inbred C57BL , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/immunology , Respiratory Tract Infections/immunology , Signal Transduction , PeroxidasinABSTRACT
Aim: Pineapple (Ananas comosus (L.) Merr.) is a good source of bromelain (B) and also contain peroxidase. The objective of this study is isoaltion of bromelain plus peroxidase (BP) from the pineapple fruit to evaluate the anticancer activity of BP from the pineapple fruit of Tripura, compared to commercial bromelain against ascitic Dalton's lymphoma cells (DLA) in mice. Methods: By acetone precipitation BP was isolated from the pineapple. Animals bearing DLA, receive B and BP orally for 15 alternative days. Apoptotic proteins are assayed using western blot. Results: BP treated mice showed recover of hemoglobin and WBC count compared to control lymphoma animal. The animal showed significant reduction of body weight due to reduced tunor load and elevated reactive oxygen species (ROS) production, elevated levels of vitamin C and vitamin E and other antioxidants in blood after BP treatment. Histology of liver and kidney also shows restored architecture in BP treated animal compared to only B treated group. BP treatment upregulates the cytochrome C, BAD, and BAX protein and downregulates the Bcl-2 and NF-kß occuring upon BP treatment in the DLA cells collected from lymphoma animal. This induce the apoptosis of DLA cells in lymphoma animal and reduce the tumor load. Conclusion: The present findings suggest that BP from pineapple improves the survival of the induced lymphoma animal compared to only B which may be used as therapeutic target.
Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Bromelains/pharmacology , Lymphoma, Non-Hodgkin/drug therapy , Peroxidase/pharmacology , Plant Extracts/pharmacology , Ananas/chemistry , Animals , Antioxidants/metabolism , Catalase/metabolism , Cell Line, Tumor , Humans , Lymphoma, Non-Hodgkin/metabolism , Lymphoma, Non-Hodgkin/pathology , Mice , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Up-Regulation/drug effectsABSTRACT
E-101 solution is a first-in-class myeloperoxidase-mediated antimicrobial developed for topical application. It is composed of porcine myeloperoxidase (pMPO), glucose oxidase (GO), glucose, sodium chloride, and specific amino acids in an aqueous solution. Once activated, the reactive species hydrogen peroxide (H2O2), hypochlorous acid, and singlet oxygen are generated. We evaluated the treatment effects of E-101 solution and its oxidative products on ultrastructure changes and microbicidal activity against methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli Time-kill and transmission electron microscopy studies were also performed using formulations with pMPO or GO omitted. The glutathione membrane protection assay was used to study the neutralization of reactive oxygen species. The potency of E-101 solution was also measured in the presence of serum and whole blood by MIC and minimal bactericidal concentration (MBC) determinations. E-101 solution demonstrated rapid bactericidal activity and ultracellular changes in MRSA and E. coli cells. When pMPO was omitted, high levels of H2O2 generated from GO and glucose demonstrated slow microbicidal activity with minimal cellular damage. When GO was omitted from the formulation, no antimicrobial activity or cellular damage was observed. Protection from exposure to E-101 solution reactive oxygen species in the glutathione protection assay was competitive and temporary. E-101 solution maintained its antimicrobial activity in the presence of inhibitory substances, such as serum and whole blood. E-101 solution is a potent myeloperoxidase enzyme system with multiple oxidative mechanisms of action. Our findings suggest that the primary site where E-101 solution exerts microbicidal action is the cell membrane, by inactivation of essential cell membrane components.
Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Peroxidase/chemistry , Peroxidase/pharmacology , Animals , Cell Membrane/drug effects , Cell Membrane/metabolism , Escherichia coli/drug effects , Escherichia coli/metabolism , Glucose Oxidase/chemistry , Glucose Oxidase/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/metabolism , Oxidation-Reduction , Reactive Oxygen Species/chemistry , Reactive Oxygen Species/pharmacology , SwineABSTRACT
Objective- The leukocyte heme-enzyme MPO (myeloperoxidase) exerts proinflammatory effects on the vascular system primarily linked to its catalytic properties. Recent studies have shown that MPO, depending on its cationic charge, mediates neutrophil recruitment and activation. Here, we further investigated MPO's extracatalytic properties and its effect on endothelial glycocalyx (EG) integrity. Approach and Results- In vivo staining of murine cremaster muscle vessels with Alcian Blue 8GX provided evidence of an MPO-dependent decrease in anionic charge of the EG. MPO binding to the glycocalyx was further characterized using Chinese hamster ovary cells and its glycosaminoglycan mutants-pgsA-745 (mutant Chinese hamster ovary cells lacking heparan sulfate and chondroitin sulfate glycosaminoglycan) and pgsD-677 (mutant Chinese hamster ovary cells lacking heparan sulfate glycosaminoglycan), which revealed heparan sulfate as the main mediator of MPO binding. Further, EG integrity was assessed in terms of thickness using intravital microscopy of murine cremaster muscle. A significant reduction in EG thickness was observed on infusion of catalytically active MPO, as well as mutant inactive MPO and cationic polymer polylysine. Similar effects were also observed in wild-type mice after a local inflammatory stimulus but not in MPO-knockout mice. The reduction in EG thickness was reversed after removal of vessel-bound MPO, suggesting a possible physical collapse of the EG. Last, experiments with in vivo neutrophil depletion revealed that MPO also induced neutrophil-mediated shedding of the EG core protein, Sdc1 (syndecan-1). Conclusions- These findings provide evidence that MPO, via ionic interaction with heparan sulfate side chains, can cause neutrophil-dependent Sdc1 shedding and collapse of the EG structure.
Subject(s)
Abdominal Muscles/blood supply , Endothelial Cells/drug effects , Glycocalyx/drug effects , Peroxidase/metabolism , Animals , CHO Cells , Cations , Cricetulus , Endothelial Cells/metabolism , Endothelial Cells/pathology , Glycocalyx/metabolism , Glycocalyx/pathology , Heparan Sulfate Proteoglycans/metabolism , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/pathology , Humans , Male , Mice, Inbred C57BL , Mice, Knockout , Neutrophil Activation , Neutrophils/drug effects , Neutrophils/metabolism , Peroxidase/deficiency , Peroxidase/genetics , Peroxidase/pharmacology , Protein Binding , Syndecan-1/metabolismABSTRACT
Carbon nanotubes (CNTs) and their derivatives have emerged as a series of efficient biocatalysts to mimic the function of natural enzymes in recent years. However, the unsatisfiable enzymatic efficiency usually limits their practical usage ranging from materials science to biotechnology. Here, for the first time, we present the synthesis of several oxygenated-group-enriched carbon nanotubes (o-CNTs) via a facile but green approach, as well as their usage as high-performance peroxidase mimics for biocatalytic reaction. Exhaustive characterizations of the enzymatic activity of o-CNTs have been provided by exploring the accurate effect of various oxygenated groups on their surface including carbonyl, carboxyl, and hydroxyl groups. Because of the "competitive inhibition" effect among all of these oxygenated groups, the catalytic efficiency of o-CNTs is significantly enhanced by weakening the presence of noncatalytic sites. Furthermore, the admirable enzymatic activity of these o-CNTs has been successfully applied in the treatment of bacterial infections, and the results of both in vitro and in vivo nanozyme-mediated bacterial clearance clearly demonstrate the feasibility of o-CNTs as robust peroxidase mimics to effectively decrease the bacterial viability under physiological conditions. We believe that the present study will not only facilitate the construction of novel efficient nanozymes by rationally adjusting the degree of the "competitive inhibition" effect, but also broaden the biological usage of o-CNT-based nanomaterials via their satisfactory enzymatic activity.
Subject(s)
Anti-Bacterial Agents/chemistry , Biomimetic Materials/chemistry , Nanotubes, Carbon/chemistry , Oxygen/chemistry , Peroxidase/chemistry , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Bacterial Infections/drug therapy , Biocatalysis , Biomimetic Materials/pharmacology , Biomimetic Materials/therapeutic use , Biomimetics , Catalysis , Mice , Oxygen/pharmacology , Peroxidase/pharmacology , Peroxidase/therapeutic use , Wound Healing/drug effectsABSTRACT
BACKGROUND AND OBJECTIVE: Little is known about the initiation of dysbiosis in oral biofilms, a topic of prime importance for understanding the etiology of, and preventing, periodontitis. The aim of this study was to evaluate the effect of different concentrations of crevicular and salivary peroxidase and catalase on dysbiosis in multispecies biofilms in vitro. MATERIAL AND METHODS: The spotting technique was used to identify the effect of different concentrations of myeloperoxidase, lactoperoxidase, erythrocyte catalase, and horseradish peroxidase in salivary and crevicular fluid on the inhibitory effect of commensals on pathobiont growth. Vitality-quantitative real-time PCR was performed to quantify the dysbiotic effect of the peroxidases (adjusted to concentrations found in periodontal health, gingivitis, and periodontitis) on multispecies microbial communities. RESULTS: Agar plate and multispecies ecology experiments showed that production of hydrogen peroxide (H2 O2 ) by commensal bacteria decreases pathobiont growth and colonization. Peroxidases at concentrations found in crevicular fluid and saliva neutralized this inhibitory effect. In multispecies communities, myeloperoxidase, at the crevicular fluid concentrations found in periodontitis, resulted in a 1-3 Log increase in pathobionts when compared with the crevicular fluid concentrations found in periodontal health. The effect of salivary lactoperoxidase and salivary myeloperoxidase concentrations was, in general, similar to the effect of crevicular myeloperoxidase concentrations. CONCLUSIONS: Commensal species suppress pathobionts by producing H2 O2 . Catalase and peroxidases, at clinically relevant concentrations, can neutralize this effect and thereby can contribute to dysbiosis by allowing the outgrowth of pathobionts.
Subject(s)
Bacteria/drug effects , Biofilms/drug effects , Dysbiosis/ethnology , Peroxidases/metabolism , Peroxidases/pharmacology , Bacteria/classification , Bacteria/metabolism , Bioreactors , Catalase/analysis , Erythrocytes/metabolism , Gingival Crevicular Fluid/chemistry , Gingival Crevicular Fluid/enzymology , Gingivitis/complications , Gingivitis/microbiology , Horseradish Peroxidase/analysis , Humans , Hydrogen Peroxide/metabolism , Lactoperoxidase/metabolism , Lactoperoxidase/pharmacology , Microbiota , Periodontitis/complications , Periodontitis/microbiology , Peroxidase/metabolism , Peroxidase/pharmacology , Saliva/chemistry , Saliva/enzymologyABSTRACT
Myeloperoxidase (MPO) is a heme enzyme abundantly expressed in polymorphonuclear neutrophils. MPO is enzymatically capable of catalyzing the generation of reactive oxygen species (ROS) and the consumption of nitric oxide (NO). Thus MPO has both potent microbicidal and, upon binding to the vessel wall, pro-inflammatory properties. Interestingly, MPO - a highly cationic protein - has been shown to bind to both endothelial cells and leukocyte membranes. Given the anionic surface charge of red blood cells, we investigated binding of MPO to erythrocytes. Red blood cells (RBCs) derived from patients with elevated MPO plasma levels showed significantly higher amounts of MPO by flow cytometry and ELISA than healthy controls. Heparin-induced MPO-release from patient-derived RBCs was significantly increased compared to controls. Ex vivo experiments revealed dose and time dependency for MPO-RBC binding, and immunofluorescence staining as well as confocal microscopy localized MPO-RBC interaction to the erythrocyte plasma membrane. NO-consumption by RBC-membrane fragments (erythrocyte "ghosts") increased with incrementally greater concentrations of MPO during incubation, indicating preserved catalytic MPO activity. In vivo infusion of MPO-loaded RBCs into C57BL/6J mice increased local MPO tissue concentrations in liver, spleen, lung, and heart tissue as well as within the cardiac vasculature. Further, NO-dependent relaxation of aortic rings was altered by RBC bound-MPO and systemic vascular resistance significantly increased after infusion of MPO-loaded RBCs into mice. In summary, we find that MPO binds to RBC membranes in vitro and in vivo, is transported by RBCs to remote sites in mice, and affects endothelial function as well as systemic vascular resistance. RBCs may avidly bind circulating MPO, and act as carriers of this leukocyte-derived enzyme.
Subject(s)
Acute Coronary Syndrome/blood , Erythrocytes/metabolism , Heart Failure/blood , Peroxidase/blood , Acute Coronary Syndrome/pathology , Animals , Aorta/drug effects , Biological Transport , Cells, Cultured , Endothelium, Vascular/drug effects , Erythrocytes/pathology , Heart/drug effects , Heart Failure/pathology , Heparin/chemistry , Humans , Male , Mice , Mice, Inbred C57BL , Nitric Oxide/metabolism , Nitric Oxide/pharmacology , Organ Culture Techniques , Peroxidase/pharmacology , Protein Binding , Tissue Culture Techniques , Vascular Resistance/drug effectsABSTRACT
Bacterial infection often leads to failed wound healing, causing one-third of death cases globally. However, antibacterial nanomaterials and natural enzymes face limitations including low antibacterial efficiency, lack of catalytic performance, low safety, and instability. Therefore, a new Fe/N-doped chitosan-chelated carbon dot-based nanozyme CS@Fe-N CDs was developed, which showed multiple advantages such as highly efficient antibacterial activity, excellent peroxidase-like activity, high stability, and high biocompatibility, shortening the wound healing time. The ultra-small (6.14 ± 3.38 nm) CS@Fe-N CDs nanozyme accelerated the H2O2 to ·OH conversion, exhibiting excellent antibacterial performance against Staphylococcus aureus. The antibacterial activity was increased by over 2000-fold after catalysis. The CS@Fe-N CDs nanozyme also displayed outstanding peroxidase activity (Vmax/Km = 1.77 × 10-6/s), 8.8-fold higher than horseradish peroxidase. Additionally, the CS@Fe-N CDs nanozyme exhibited high stability at broad pH values (pH 1-12) and temperature ranges (20-90 °C). In vitro evaluation of cell toxicity proved that the CS@Fe-N CDs nanozyme had negligible cytotoxicity. In vivo, wound healing experiments demonstrated that the CS@Fe-N CDs could shorten the healing time of rat wounds by at least 4 days, and even had a better curative effect than penicillin. In conclusion, this therapeutic platform provides an effective antibacterial and biologically safe healing strategy for skin wounds.
Subject(s)
Chitosan , Rats , Animals , Chitosan/pharmacology , Carbon/pharmacology , Hydrogen Peroxide/pharmacology , Anti-Bacterial Agents/pharmacology , Wound Healing , Antioxidants/pharmacology , Peroxidases/pharmacology , Peroxidase/pharmacologyABSTRACT
Brain-derived neurotrophic factor (BDNF) increases in failing hearts, but BDNF roles in cardiac remodeling following myocardial infarction (MI) are unclear. Male BDNF(+/+) [wild-type (WT)] and BDNF(+/-) heterozygous (HET) mice at 6-9 mo of age were subjected to MI and evaluated at days 1, 3, 5, 7, or 28 post-MI. At day 28 post-MI, 76% of HET versus 40% of WT survived, whereas fractional shortening improved and neovascularization levels were reduced in the HET (all, P < 0.05). At day 1, post-MI, matrix metalloproteinase-9, and myeloperoxidase (MPO) increased in WT, but not in HET. Concomitantly, monocyte chemotactic protein-1 and -5 levels increased and vascular endothelial growth factor (VEGF)-A decreased in HET. Neutrophil infiltration peaked at days 1-3 in WT mice, and this increase was blunted in HET. To determine if MPO administration could rescue the HET phenotype, MPO was injected at 3 h post-MI. MPO restored VEGF-A levels without altering matrix metalloproteinase-9 or neutrophil content. In conclusion, reduced BDNF levels modulated the early inflammatory and neovascularization responses, leading to improved survival and reduced cardiac remodeling at day 28 post-MI. Thus reduced BDNF attenuates early inflammation following MI by modulating MPO and angiogenic response through VEGF-A.